Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib ambulatory blood pressure study in rheumatoid arthritis
2011-006070-73Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Fostamatinib + DMARD with Placebo + DMARD (2 arms). Primary endpoint: Mean change from baseline in 24-hour mean ambulatory systolic blood pressure. Started Feb 2012; status: completed.
02
Drugs
fostamatinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-006070-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006070-73.